New Results Medical Weight Loss

New Results Medical Weight Loss operates as a physician-supervised weight loss clinic in Scottsdale, Arizona, focusing on pharmaceutical-grade peptide therapies and hormone optimization protocols for patients seeking medically managed weight reduction. The clinic structures its programs around GLP-1 receptor agonist peptides—specifically tirzepatide and semaglutide—which work through appetite suppression and metabolic regulation mechanisms. Patients receive in-person consultations where providers assess metabolic health markers, body composition, and hormonal status before designing individualized treatment protocols that may combine peptide therapy with nutritional guidance and hormone balancing interventions.

The clinic's peptide therapy protocols center on two FDA-approved medications: semaglutide, which mimics the GLP-1 hormone to reduce appetite and slow gastric emptying, and tirzepatide, a dual GIP/GLP-1 receptor agonist that targets both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 pathways. New Results Medical Weight Loss administers these peptides through subcutaneous injection protocols, with patients receiving pharmaceutical-grade vials for self-administration between clinic visits. The Scottsdale practice supplements peptide therapy with vitamin B12 injections to support energy metabolism during caloric restriction phases, and offers testosterone replacement therapy (TRT) for patients whose hormone panels reveal hypogonadism or suboptimal testosterone levels that may impair weight loss efforts. Treatment plans typically involve weekly or bi-weekly peptide dosing with monthly follow-up appointments to monitor progress and adjust protocols based on patient response.

The medical team at New Results Medical Weight Loss conducts comprehensive initial evaluations that include metabolic panel testing, body composition analysis, and hormone level assessment to identify physiological factors affecting weight management. Providers review patient medical histories to screen for contraindications to GLP-1 therapy, such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. The clinic's approach integrates peptide pharmacotherapy with dietary modification strategies, though the specific nutritional protocols are tailored to individual metabolic profiles rather than following a single dietary template. For patients with hormone imbalances contributing to weight gain or metabolic dysfunction, the practice offers hormone optimization services that may include thyroid hormone evaluation and testosterone therapy for appropriate candidates.

Patients attending New Results Medical Weight Loss in Scottsdale receive in-person care throughout their treatment journey, with initial consultations involving physical examination, laboratory work review, and treatment goal establishment. The clinic provides instruction on proper peptide injection technique, including injection site rotation and sterile handling of medication vials. Follow-up visits track weight loss progression, assess tolerance to peptide therapy, and monitor for side effects such as nausea or gastrointestinal symptoms common with GLP-1 medications. The practice maintains a structured program format where patients follow defined protocols with regular accountability checkpoints, allowing providers to make real-time adjustments to peptide dosing or adjunctive therapies based on individual response patterns. Patients receive ongoing access to the medical team for questions about medication administration, side effect management, or program adherence challenges.

New Results Medical Weight Loss differentiates itself in the Scottsdale medical weight loss market through its focus on pharmaceutical-grade peptide therapies rather than relying primarily on behavioral modification or non-prescription supplements. The clinic's integration of hormone optimization services addresses the endocrine factors that frequently undermine weight loss efforts, particularly in patients over 40 experiencing age-related hormonal decline. By requiring in-person consultations rather than operating as a telehealth-only service, the practice enables direct physical assessment and establishes continuity of care with consistent provider relationships. The clinic's combination of tirzepatide and semaglutide options allows providers to select the most appropriate GLP-1 therapy based on patient-specific factors such as insurance coverage, tolerance profiles, and weight loss goals, while the availability of adjunctive therapies like B12 and testosterone creates comprehensive treatment plans that address multiple metabolic pathways simultaneously.